市場調査レポート
商品コード
1375983

止血剤・組織シーリング剤の市場規模、シェア、動向、市場分析、製品別、地域別、セグメント予測、2023年~2030年

Hemostasis And Tissue Sealing Agents Market Size, Share & Trends Market Analysis By Product (Topical Hemostat, Adhesive & Tissue Sealant), By Region (Europe, APAC, North America), And Segment Forecasts, 2023 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 150 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.16円
止血剤・組織シーリング剤の市場規模、シェア、動向、市場分析、製品別、地域別、セグメント予測、2023年~2030年
出版日: 2023年10月20日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

止血剤・組織シーリング剤市場の成長と動向:

Grand View Research, Inc.の最新レポートによると、世界の止血剤・組織シーリング剤市場規模は、2023年から2030年にかけてCAGR 8.9%を記録し、2030年までに144億7,000万米ドルに達すると予測されています。

この薬剤は、出血を予防する能力により、時とともに人気を博してきました。低侵襲技術の急成長と患者の早期回復要求は、予測期間中の市場成長を促進すると予想されます。米国疾病予防管理センター(CDC)によると、現在、米国人口の約1億5,000万人が少なくとも1つの慢性疾患に罹患しており、手術や死亡に至ることさえあります。

CDCの推計によると、アメリカ全人口の48%以上が慢性疾患に苦しむと予想されています。この市場は、手術件数の増加に支えられた製品需要の増加により、今後7年間で有利な成長が見込まれます。高齢者人口の増加と慢性疾患の蔓延も市場を牽引する主要因の一つです。2019年12月、ジョンソン・エンド・ジョンソンの一部門であるEthiconは、低侵襲処置や開腹手術中に過剰な出血を迅速かつ効率的に制御し、封鎖するように設計された止血用タンパク質スプレーを発売しました。

COVID-19の大流行中、ウイルスに感染した患者の重症例では、敗血症性ショックや急性呼吸窮迫症候群(ARDS)を発症する傾向がみられ、ICUでの特別なケアが必要であり、慢性的な障害が残り、長期的な成績は不良でした。ICUに入室しているこれらの患者では、基礎疾患や臓器機能障害を示す凝固異常がよく見られます。これが、止血・組織シーリング製品の需要増加の主な要因の一つとなっています。

止血剤・組織シーリング剤市場のレポートハイライト

  • 市場成長の背景には、世界の手術件数の増加と、低収縮性ショック、血小板減少症、輸血、術後合併症の発生を回避するための様々な手術における製品の適用性があります。
  • 局所止血材セグメントは、2022年に67.2%と最大の売上シェアを占めました。また、従来の治療と併用することで費用対効果が高いこと、止血剤の吸収性が迅速かつ容易であること、組織反応性が最小であること、抗原性がないことなどから、予測期間中にCAGR 9.2%の急成長が見込まれています。
  • 接着剤・組織シーラント分野は、予測期間中CAGR 8.1%で成長する見込みです。接着剤と組織シーラントは、外科手術中の出血をコントロールするのに重要であり、損傷した組織と結合して密封することで機能します。
  • 北米が市場を独占し、2022年には33.1%の最大収益シェアを占めました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 止血剤・組織シーリング剤の市場変数、動向および範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 普及と成長の見通しマッピング
  • 業界のバリューチェーン分析
    • 償還の枠組み
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 止血剤・組織シーリング剤市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 止血剤・組織シーリング剤市場:製品別推定・動向分析

  • 止血剤・組織シーリング剤市場:重要なポイント
  • 止血剤・組織シーリング剤市場:動向および市場シェア分析、2022年および2030年
  • 局所止血剤
  • 接着剤およびティッシュシーラント

第5章 止血剤・組織シーリング剤市場:地域別推定・動向分析

  • 地域別の見通し
  • 地域別の止血剤・組織シーリング剤市場:重要なポイント
  • 北米
    • 市場推計・予測、2018~2030年
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • スウェーデン
    • ノルウェー
    • デンマーク
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • クウェート

第6章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 市場参入企業の分類
    • Johnson & Johnson
    • Artivion, Inc
    • Pfizer
    • C R Bard
    • B Braun
    • Covidien
    • Advance Medical Solutions Group
    • Smith & Nephew
図表

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 3 North America hemostasis & tissue sealing agents market, by region, 2018 - 2030 (USD Million)
  • Table 4 U.S. hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 5 Canada hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 6 Europe hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 7 Europe hemostasis & tissue sealing agents market, by region, 2018 - 2030 (USD Million)
  • Table 8 Germany hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 9 UK hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 10 France hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 11 Italy hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 12 Spain hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 13 Sweden hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 14 Norway hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 15 Denmark hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 16 Asia Pacific hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 17 Asia Pacific hemostasis & tissue sealing agents market, by region, 2018 - 2030 (USD Million)
  • Table 18 China hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 19 Japan hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 20 India hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 21 Australia hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 22 Thailand hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 23 South Korea hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 24 Latin America hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 25 Latin America hemostasis & tissue sealing agents market, by region, 2018 - 2030 (USD Million)
  • Table 26 Brazil hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 27 Mexico hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 28 Argentina hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 29 Middle East and Africa hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 30 Middle East and Africa hemostasis & tissue sealing agents market, by region, 2018 - 2030 (USD Million)
  • Table 31 South Africa hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 32 Saudi Arabia hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 33 UAE hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 34 Kuwait hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Hemostasis & tissue sealing agents: Market outlook
  • Fig. 9 Hemostasis & tissue sealing agents: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Hemostasis & tissue sealing agents market driver impact
  • Fig. 15 Hemostasis & tissue sealing agents market restraint impact
  • Fig. 16 Hemostasis & Tissue Sealing Agents Market Strategic Initiatives Analysis
  • Fig. 17 Hemostasis & tissue sealing agents market: Product movement analysis
  • Fig. 18 Hemostasis & tissue sealing agents market: Product outlook and key takeaways
  • Fig. 19 Topical hemostat market estimates and forecasts, 2018 - 2030
  • Fig. 20 Active market estimates and forecasts, 2018 - 2030
  • Fig. 21 Mechanical market estimates and forecasts, 2018 - 2030
  • Fig. 22 Flowable market estimates and forecasts, 2018 - 2030
  • Fig. 23 Adhesives & tissue sealant market estimates and forecasts, 2018 - 2030
  • Fig. 24 Synthetic tissue sealant market estimates and forecasts, 2018 - 2030
  • Fig. 25 Natural tissue sealant market estimates and forecasts, 2018 - 2030
  • Fig. 26 Adhesion barrier products market estimates and forecasts, 2018 - 2030
  • Fig. 27 Global Hemostasis & tissue sealing agents market: Regional movement analysis
  • Fig. 28 Global Hemostasis & tissue sealing agents market: Regional outlook and key takeaways
  • Fig. 29 North America market estimates and forecasts, 2018 - 2030
  • Fig. 30 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 31 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 32 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 33 U.K. market estimates and forecasts, 2018 - 2030
  • Fig. 34 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 35 France market estimates and forecasts, 2018 - 2030
  • Fig. 36 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 37 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 38 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 39 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 40 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 41 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 42 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 43 China market estimates and forecasts, 2018 - 2030
  • Fig. 44 India market estimates and forecasts, 2018 - 2030
  • Fig. 45 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 46 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 47 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 48 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 49 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 50 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 51 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 52 Middle East and Africa. market estimates and forecasts, 2018 - 2030
  • Fig. 53 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 54 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 55 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 56 Kuwait market estimates and forecasts, 2018 - 2030
目次
Product Code: 978-1-68038-597-7

Hemostasis And Tissue Sealing Agents Market Growth & Trends:

The global hemostasis and tissue sealing agents market size is expected to reach USD 14.47 billion by 2030, registering a CAGR of 8.9% from 2023 to 2030, according to a new report by Grand View Research, Inc.. The agents have gained popularity over time due to their ability to prevent blood loss. The rapid growth of minimally invasive technology and the demand for faster recovery by patients are expected to promote market growth over the forecast period. According to the Centers for Disease Control and Prevention (CDC), approximately 150 million of the American population are currently suffering from at least one chronic condition, which leads to surgeries and even mortality at times.

An estimate over the rising incidence was made by the CDC, which concluded that over 48% of the entire American population is expected to suffer from chronic conditions. The market is expected to witness lucrative growth over the next seven years owing to an increase in product demand supported by the rising surgery volumes. Growth in the geriatric population and the prevalence of chronic conditions are also among the key factors driving the market. In December 2019, the Ethicon, a unit of Johnson & Johnson, launched its protein spray for blood-stopping, designed to quickly & efficiently control and seal off excessive bleeding during minimally invasive procedures and open surgeries.

During the COVID-19 pandemic, severe cases among patients infected by the virus have shown the tendency to develop septic shock and Acute Respiratory Distress Syndrome (ARDS), demanding special care in ICU, with residual chronic disability and poor long-term results. Among these patients in the ICU, Coagulopathy has been commonly noticed indicating underlying diseases and organ dysfunction. This has been one of the major contributing factors to the increasing demand for hemostasis & tissue sealing products.

Hemostasis And Tissue Sealing Agents Market Report Highlights:

  • The market growth can be attributed to a rise in the global volume of surgeries and the applicability of the product across a variety of surgeries to avoid the occurrence of hypovolemic shock, thrombocytopenia, blood transfusions, and postoperative complications
  • The topical hemostat segment accounted for the largest revenue share of 67.2% in 2022. In addition, a segment is expected to grow at the fastest CAGR of 9.2% during the forecast period due to its use with conventional treatment to provide cost-efficiency, quick & easy absorbability of the hemostatic agent, minimal tissue reactivity, and non-antigenicity.
  • The adhesive & tissue sealant segment is expected to grow at a CAGR of 8.1% over the forecast period. Adhesives and tissue sealants are crucial in controlling blood loss during surgical procedures and function by binding with and sealing the damaged tissues.
  • North America dominated the market and accounted for the largest revenue share of 33.1% in 2022, owing to the growing prevalence of cardiovascular disorders, diabetes, and cancer within the region.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Material outlook
    • 2.2.3. Application outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Hemostasis & Tissue Sealing Agents Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Reimbursement framework
  • 3.4. Market Dynamics
    • 3.4.1. Market Driver Analysis
    • 3.4.2. Market Restraint Analysis
  • 3.5. Hemostasis & Tissue Sealing Agents Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. Threat of new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic landscape

Chapter 4. Hemostasis & Tissue Sealing Agents Market: Product Estimates & Trend Analysis

  • 4.1. Hemostasis & Tissue Sealing Agents Market: Key Takeaways
  • 4.2. Hemostasis & Tissue Sealing Agents Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Topical Hemostat
    • 4.3.1. Topical Hemostat market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.3.1.1. Active market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.3.2.2. Mechanical market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.3.2.3 Flowable market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Adhesive & Tissue Sealant
    • 4.4.1. Adhesive & tissue sealant market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.1. Synthetic tissue sealant market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.2. Natural tissue sealant market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.3. Adhesion barrier products market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Hemostasis & Tissue Sealing Agents Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Outlook
  • 5.2. Hemostasis & Tissue Sealing Agents Market by Region: Key Takeaway
  • 5.3. North America
    • 5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.2. U.S.
      • 5.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.3. Canada
      • 5.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.4. Europe
    • 5.4.1. U.K.
      • 5.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.2. Germany
      • 5.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.3. France
      • 5.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.4. Italy
      • 5.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.5. Spain
      • 5.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.6. Sweden
      • 5.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.7. Norway
      • 5.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.8. Denmark
      • 5.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Japan
      • 5.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.2. China
      • 5.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.3. India
      • 5.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.4. Australia
      • 5.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.5. Thailand
      • 5.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.6. South Korea
      • 5.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.6. Latin America
    • 5.6.1. Brazil
      • 5.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.2. Mexico
      • 5.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.3. Argentina
      • 5.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.7. MEA
    • 5.7.1. Saudi Arabia
      • 5.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.2. South Africa
      • 5.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.3. UAE
      • 5.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.4. Kuwait
      • 5.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Market Participant Categorization
    • 6.2.1. Johnson & Johnson
      • 6.2.1.1. Company overview
      • 6.2.1.2. Financial performance
      • 6.2.1.3. Product benchmarking
      • 6.2.1.4. Strategic initiatives
    • 6.2.2. Artivion, Inc
      • 6.2.2.1. Company overview
      • 6.2.2.2. Financial performance
      • 6.2.2.3. Product benchmarking
      • 6.2.2.4. Strategic initiatives
    • 6.2.3. Pfizer
      • 6.2.3.1. Company overview
      • 6.2.3.2. Financial performance
      • 6.2.3.3. Product benchmarking
      • 6.2.3.4. Strategic initiatives
    • 6.2.4. C R Bard
      • 6.2.4.1. Company overview
      • 6.2.4.2. Financial performance
      • 6.2.4.3. Product benchmarking
      • 6.2.4.4. Strategic initiatives
    • 6.2.5. B Braun
      • 6.2.5.1. Company overview
      • 6.2.5.2. Financial performance
      • 6.2.5.3. Product benchmarking
      • 6.2.5.4. Strategic initiatives
    • 6.2.6. Covidien
      • 6.2.6.1. Company overview
      • 6.2.6.2. Financial performance
      • 6.2.6.3. Product benchmarking
      • 6.2.6.4. Strategic initiatives
    • 6.2.7. Advance Medical Solutions Group
      • 6.2.7.1. Company overview
      • 6.2.7.2. Financial performance
      • 6.2.7.3. Product benchmarking
      • 6.2.7.4. Strategic initiatives
    • 6.2.8. Smith & Nephew
      • 6.2.8.1. Company overview
      • 6.2.8.2. Financial performance
      • 6.2.8.3. Product benchmarking
      • 6.2.8.4. Strategic initiatives